---
pmid: '31837836'
title: d-Glycerate kinase deficiency in a neuropediatric patient.
authors:
- Sass JO
- Behringer S
- Fernando M
- Cesaroni E
- Cursio I
- Volpini A
- Till C
journal: Brain Dev
year: '2020'
full_text_available: false
doi: 10.1016/j.braindev.2019.11.008
---

# d-Glycerate kinase deficiency in a neuropediatric patient.
**Authors:** Sass JO, Behringer S, Fernando M, Cesaroni E, Cursio I, Volpini A, Till C
**Journal:** Brain Dev (2020)
**DOI:** [10.1016/j.braindev.2019.11.008](https://doi.org/10.1016/j.braindev.2019.11.008)

## Abstract

1. Brain Dev. 2020 Feb;42(2):226-230. doi: 10.1016/j.braindev.2019.11.008. Epub 
2019 Dec 11.

d-Glycerate kinase deficiency in a neuropediatric patient.

Sass JO(1), Behringer S(2), Fernando M(2), Cesaroni E(3), Cursio I(4), Volpini 
A(5), Till C(6).

Author information:
(1)Research Group Inborn Errors of Metabolism, Department of Natural Sciences 
and Institute for Functional Gene Analytics (IFGA), Bonn-Rhein-Sieg University 
of Applied Sciences, von-Liebig-Str. 20, 53359 Rheinbach, Germany. Electronic 
address: joern.oliver.sass@h-brs.de.
(2)Laboratory of Clinical Biochemistry & Metabolism, University of Freiburg 
Children's Hospital, Mathildenstr. 1, 79106 Freiburg, Germany.
(3)Department of Neuropsychiatry, Children's Hospital "G. Salesi", AOU Ospedali 
Riuniti Ancona, Italy.
(4)Department of Neuropsychiatry, Children's Hospital "G. Salesi", AOU Ospedali 
Riuniti Ancona, Italy; Child and Adolescent Neuropsychiatry Unit, University of 
Cagliari, Cagliari, Italy.
(5)Department of Pediatrics, Children's Hospital "G. Salesi", AOU Ospedali 
Riuniti Ancona, Italy.
(6)Research Group Inborn Errors of Metabolism, Department of Natural Sciences 
and Institute for Functional Gene Analytics (IFGA), Bonn-Rhein-Sieg University 
of Applied Sciences, von-Liebig-Str. 20, 53359 Rheinbach, Germany.

d-Glyceric aciduria (DGA) due to d-glycerate kinase deficiency (DGKD) is a rare 
autosomal-recessive inborn error of metabolism that is usually linked to the 
metabolism of fructose and serine. We describe a Moroccan patient with DGKD 
whose metabolic defect has been characterized by metabolite studies, sequencing 
of genomic DNA and by studies on the RNA level. Since birth the index patient 
presented with severe muscular hypotonia, joint hypermobility and tremor. 
Enantioselective analysis showed elevated d-glyceric acid in the urine of the 
patient, but not in that of his parents. DNA analysis revealed homozygosity in 
the GLYCTK gene for c.517G>T [p.(Val173Leu)], the first mutation reported for 
exon 3 of this gene, as well as for the c.530-4A>G polymorphism. RNA studies 
suggest that none of these sequence variants affects splicing. The mother was 
heterozygous for both sequence variants, the father heterozygous for the first 
one and homozygous for the polymorphism, which further supports that c.517G>T is 
the functionally relevant nucleotide change. The conservation of GLYCTK 
throughout evolution suggests an important biological role of this enzyme, 
although it is not known yet how mutations are linked to clinical features. 
Future studies should investigate the molecular defect in a more general way and 
search for additional roles of GLYCTK beyond its established role in catabolism 
of serine and fructose.

Copyright Â© 2019 The Japanese Society of Child Neurology. Published by Elsevier 
B.V. All rights reserved.

DOI: 10.1016/j.braindev.2019.11.008
PMID: 31837836 [Indexed for MEDLINE]
